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ABSTRACT
Objective: Intestinal microsporidia is an emerging human disease caused by microsporidia.
A study was conducted to determine the prevalence of microsporidia in patients with
gastro-intestinal symptoms and to examine the clinical manifestations associated with
intestinal microsporidiosis. Methods: A descriptive cross-sectional study using a well-
structured questionnaire; a review of medical records was also undertaken. Positive stool
samples were defined as presence of one or more pinkish-violet ovoid structures with a
belt-like stripe under high power field (lOOx) using modified gram-chromotrope stain
(MGC). Results: A total of 353 faecal specimens of patients was examined and 100
patients were found to have positive stool samples for microsporidia. The overall prevalence
of microsporidia was 28.3%. Acute and chronic diarrhoea were seen in 49.0% and 36.0%
patients, respectively. The commonest clinical presentations were diarrhoea (85.0%) with
83.0 % of patients having loose or watery stools, vomiting (75.0%), foul-smelling stools
(60.0%), nausea (59.0%) and cramping abdominal pain (39.0%). The least common
symptoms were fever (15.0%), mucous in stool (5.0%) and blood in stool (4.0%).
Conclusion: This study concludes that the prevalence of microsporidia is still high (28.3%)
and the majority of patients (93.0%) are symptomatic; the most common gastro-intestinal
symptom is diarrhoea with loose or watery stools. Hence, it is recommended that a stool
screening for microsporidia be done in selected patients presented with gastrointestinal
symptoms.
Keywords: Intestinal microsporidia, gastrointestinal symptom, modified gram-
chromotrope stain (MGC), diarrhoea, loose or watery stool
IN T R O D U C T IO N
Numerous 'new' gastrointestinal pathogens have emerged in recent years, including one of
the important types of intestinal sporozoa: microsporidia. Microsporidia are an unusual
group of eukaryotic, obligate intracellular protozoan that affect both vertebrate and
invertebrate hosts. The first documented case of microsporidiosis in humans was published
in 1959 but did not gain much attention until the acquired immunodeficiency syndrome
(AIDS) pandemic developed in 1985.[I,2J Since then, microsporidia have emerged as the
aetiologic agents of opportunistic infections in persons with AIDS, other immuno-
compromised patients and also in immuno-competent indi viduals. [3.4.5.6.7.8J
Before the era of AIDS, prevalence data for microsporidia in humans was done via
serology and it was inconclusive due to several uncertainties in interpreting the results.181
Recently, it has been estimated that the prevalences in AIDS patients approximately ranged
from 5 to 50% or even higher and varied according to geographic location and diagnostic
techniques used.[9.101Furthermore, the epidemiology of microsporidia remains largely
unknown, and routes of transmission and sources of human microsporidial infections have
also been difficult to ascertain.!ll
These parasites are now known to cause a wide spectrum of clinical diseases in humans.
The species involved are Encepha litozoon cuniculi, E. hellem, E. (Septa ta ) intestina lis,
Enterocytozoon bieneusi, Tra chipleistophora hominis, Tra chipleistophora
anthropopthera , P leistophora species, Vitta forma (Nosema ) cornea e, Microspor idium
spp., Nosema ocula rum, Bra chiola (Nosema ) connor i, Bra chiola vesicula tum and
Brachiola (Nosema ) a lgera e. The diseases produced by microsporidia are commonly seen
in AIDS patients. The parasites cause a severe, non-bloody, non-mucoid diarrhoea, with up
to 10 or even more bowel movements per day, nausea, vomiting, anorexia, fever, cramping
abdominal pain, slow progressive weight loss and malabsorption of fat, D-xylose, and
vitamin BI2.111] However, in immuno-competent individuals, these parasites frequently
cause acute but self-limiting diarrhoea.[ll
Little is known about the magnitude and epidemiology of this newly emerging parasite
in Malaysia. The first description of micro sporidia in two HIV patients was reported by the
Institute for Medical Research (IMR) in the 1980s but the data was found to be inconclusive
as the role of these parasites was not properly examined due to the small number of cases
(pers. comm).
In Malaysia, a prevalence of 10.8% and 13.0% was repolted in an observational study
done in 818 patients, using gram chromotrope (GC) and modified gram chromotrope (MGC),
respectively (Norhayati et a l. pers. comm.). Another community study done by Norhayati
et a l. (pers. comm.) on asymptomatic aborigines (Orang Asli) children in Selangor revealed
a prevalence of 20.7%. Notwithstanding, the clinical manifestations of intestinal
microsporidiosis were not clearly examined.
This study was conducted to ascertain the current status on the epidemiology and
clinical manifestations of this infection in warded patients and also those managed by the
Outpatient Department of HUKM.
Study Area and Study Popula tion
This is a cross-sectional study on the relationship between the clinical manifestations of
intestinal microsporidia and the socio-demographic data of patients in Hospital Universiti
Kebangsaan Malaysia (HUKM), Cheras. Both outpatients and inpatients were enrolled
into this study which was conducted from March until December 2004. Each stool sample
was sent to the Laboratory of Medical Microbiology and Immunology in HUKM and was
given a special code without prior knowledge of the study subjects' clinical diagnosis.
Patients were informed of the purpose of this study and if they agreed to participate, a
signed consent form was obtained. The study was approved by the Research and Ethical
Committee, Faculty of Medicine, Universiti Kebangsaan Malaysia. Socio-demographic and
clinical data were obtained from the medical records and subsequently recorded into the
well-structured questionnaire that was modified from Molina et a f. l1 9 1
Structured Questionna ire
The data was collected for each stool sample sent from a patient containing the following
information as shown in Appendix 1: age, sex, clinical symptoms (fever, diarrhoea, abdominal
pain, etc.), the underlying medical conditions, type of diarrhoea, description of stool and
medical treatment.
Fresh stool samples were collected into wide-mouth screw-cap 100 ml clean containers. All
procedures were carried out in a biohazard cabinet.
A smear of faeces in 0.9% saline was examined for the presence of trophozoites, ova and
larvae of the protozoa and helminths. In addition, iodine preparation was also done for the
detection of protozoan cysts. The method of parasitic detection was performed according
to the procedure previously described by Brasil et a l. [31 and Gumbo et a l. [ 4 1
Approximately 10 gm of faeces was mixed thoroughly and a thin smear fixed in methanol
was made for the detection of microsporidian spores using modified chromotrope stain. All
slides made for the detection of parasites from the respective samples were given the
respective laboratory number and examined without knowledge of the patient's biological
data or the clinical diagnosis or HIV status.
Criteria used for the identification of the spore was the presence of one or more pinkish-
violet ovoid structures with a spore wall and a belt-like stripe, over an examination of at least
100 fields/lOOx, confirmed by two parasitologistsyl
Faecal specimens were inoculated onto the common solid media (Oxoid, Oxoid Ltd, UK)
used in the laboratory, that is, blood, deoxycholate, Camphylobacter, Clostr idium difficile
agar and Thiosulphate Citrate Bile Salt (TCBs). Growths of suspected enteric pathogens
were processed further for identification. Enrichment broths, that is, alkaline peptone water
(Oxoid, Oxoid Ltd, UK) and selenite broth (Oxoid, Oxoid Ltd, UK) were used for the recovery
of V cholera e, Sa lmonella and Shigella spp. All specimens were incubated at 3rC for 24
hours except Campylobacter jejuni specimens which were incubated at 42°C under micro-
aerophilic conditions for 48 hours. Final identification of the significant isolates was done
using Analytical Profile Index (API 20E, 20 NE [bioMerieux, Inc] North Carolina).
Detection of toxins produced by Clostr idium difficile was done using C. difficile Toxin
A test (Oxoid, Oxoid Ltd, UK). Escher ichia coli serogroup 0157 was identified by latex
agglutination test (Oxoid, Oxoid Ltd, UK). However, detection of toxins produced by
enterotoxigenic E. coli (ETEC) via PCR was not carried out as the facility was not available
during the study period.
Latex agglutination test (Rotalex, Orion Diagnostica, Finland) for rotavirus antigen detection
in stool specimens was used selectively for paediatric patients less than 5 years old. This
procedure has already been established following the standard operating procedure (SOP)
for rotavirus gastroenteritis in HUKM.
Nega tive Stool
A negative stool evaluation was defined according to Bini et al.1 1 2 1 as a specimen that was
negative for stool culture for common enteric pathogens. It also included the absence of
ova and parasites, Clostr idium difficile toxin and the latex agglutination test for rotavirus.
Sta tistica l Ana lysis
Statistical analysis of data was performed using Statistical Package for Social Sciences for
Windows SPSS 11.5 (SPSS Inc., Chicago, IL, USA). For descriptive data, rate (percentage)
was used to assess the prevalence of illness. Chi-square test was used to test for associations
between variables. Observed differences in data were considered significant if p< 0.05 was
obtained.
Genera l Cha ra cter istics of Study Popula tion
Three hundred and fifty-three patients (160 males; 193 females) participated in this study.
Among which, 71(20.1 %) were from the age group of 0-6; 22 (6.2%) in 7-12 age group; 9
(2.5%) in 13-17 age group; 60 (17.0%) in 18-30 age group; 94 (26.6%) in 31-55 age group; and
97(27.5%) aged 56 and over. All stool samples were examined for enteric pathogens within
the 90-month study period and overall prevalence of microorganisms detected was 33.7%,
while 66.3% was negative for microorganisms.
Enter ic P a thogens Isola ted from Faeca l Samples of All P a tients
Table 1 shows the prevalence of microorganisms isolated from positive faecal samples.
Amongst the 119 microorganisms isolated, microsporidia alone was the most common
pathogen detected in 28.3% patients, followed by helminths and bacteria in 1.1% and 2.0%
patients, respectively. Multiple pathogens were identified which consisted of microsporidia
and bacteria in 2.3% patients. Figure 1 shows microsporidian spores in faecal smear using
modified chromo trope stain.
P resenting Compla ints of P a tients in Rela tion to Isola tion of Enter ic P a thogens
Table 2 shows the presence of enteric pathogens in faecal specimens and presenting
complaints of patients. The most presenting symptom amongst the 109 patients with enteric
pathogens was diarrhoea at 61.8%; followed by cramping abdominal pain (24.9%), vomiting
(50.7%), nausea (41.3%), foul smelling stool (19.8%), and mucus in stool (25.8%). Blood in
stool was the least common, 4.2%. Interestingly, of the 119 subjects studied, the overall
prevalence of enteric pathogens in patients with gastro-intestinal symptoms (91.6%) was
more frequent in patients without symptoms (8.4%). The difference was statistically
significant (x2:39.l27; p= O.OOO).
Demographic P rofile of P a tients with Microspor idia
In total, 100(28.3%) stool samples were positive for microsporidia; patients aged 6 and
below (23.0%) and 31-55 (29.0%) were predominant age groups. The male: female ratio was
1.1:1, and Malays (57%) were the predominant race group followed by Chinese (30.0%),
Indians (7.0%) and (6.0%) others. Table 3 shows the general characteristics of 100 patients
with microsporidia.
Table 1. The prevalence of specific enteric pathogens detected in faecal samples
of 353 patients
Enteropathogen Number of cases
Microsporidia 100
Asca r is lumbr icoides 4
Sa lmonella spp'Escher ichia coli' 52









* Mixed with bacteria and identified as non-pathogenic E. coli, Enteroba cter spp. and
Sa lmonella spp.
t Significant isolates as patients presented with bacteraemia

















F ig u re 1 . Spores of microsporidia in a stool specimen stained with modified chromotrope. Note the
characteristic ovoid structures (arrow heads) with a belt-like stripe or equitorial line.
Original magnification, x I ,000.
Clinica l F ea tures of P a tients with Microspor idia
Amongst the 100 patients who were positive for microsporidia, the majority (85) had diarrhoea
(85.0%). Furthermore, 83 patients complained of loose or watery stools (83.0%). Forty-nine
(49.0%) of the 85 patients had acute episodes of diarrhoea. Meanwhile, 36 patients (36.0%)
had chronic episodes of diarrhoea. Acute diarrhoea is defined as a diarrhoeal episode
lasting less than four weeks while chronic diarrhoea is defined as an increase in frequency
of defecation more of than three motions per day for more than four weeks.1131
The second most common presentation was vomiting, that is in 75 cases (75.0%)
followed by foul smelling stool and nausea in 60 (60.0%), and 59 patients (59.0%), respectively.
Thirty-nine patients (39.0%) had cramping abdominal pain. Meanwhile, only 15 patients
had fever (15.0%). The least common presentations found in the 100 patients with
microsporidia were mucus and blood in their stools, in 5 (5.0%) and 4 (4.0%), patients,
respectively. Table 4 shows the signs and symtoms presented by 100 patients with
microsporidia.
D IS C U S S IO N
This study showed a high prevalence (28.3%) of intestinal microsporidia among patients
managed in HUKM compared with two previous local studies in Malaysia. Nonetheless,
the prevalence that has been reported worlwide ranges from 7.0 to 50.0%. This percentage
varies due to various reasons as reported by others.[11.13.14j
In general, detection methods have been shown to influence the prevalence data as
well as the selection of studied population and geographical variation. The method used in
this study was a modified Gram-Chromotrope stain that has a comparable level of sensitivity
T ab le 3. Demographic profile of 100 patients with
microsporidia in stool samples in HUKM, Kuala
Lumpur





6 years and below 23 23
7-12 years 8 8
13-17 years 3 3
18-30 years 15 15
31-55 years 29 29






T ab le 4 . Presenting clinical features of 100 patients with
microsporidia in their stools.






Cramping abdominal pain 39 39
Fever 15 15
Nature of stool




ranging from 80 to 100%. It is also cheaper than other advanced techniques, e.g. transmission
electron microscopy (TEM), and also can detect low numbers of microsporidian spores.
Thus, it can be used as a screening tool for clinical specimens in our country. However, the
staining procedure is quite lengthy; it takes ninety minutes to complete before the slide can
be examined. Moreover, it is operator-dependent, and may give false-negative results.[1.15.16]
Nevertheless, several modifications have been made to shorten the time and to increase
the contrast between spores and backgroundJI.II.'7J
This study also found that intestinal microsporidiosis is neither associated with gender
or race differences, as the ratio is almost equal in both males and females (1 .1 : 1 ) . Malays
were the most predominant race that had microsporidia, followed by Chinese, Indians and
others. However, one study reported that these two variables have no influence in the
acquisition of microsporidia.[181 There were also three main age groups that were most
affected such as young children less than 6 years old and the middle age group aged 3 1
and above. These findings may not reflect the true age group prevalence in the population,
as HUKM is a tertiary centre where cases are selectively referred for further management.
Also, the number of patients did not represent the entire population of Malaysia.
Patients with microsporida commonly presented with acute diarrhoea compared to
chronic diarrhoea in this study. This finding was in contrast with another study reported by
a researcher that chronic diarrhoea is the commonest presentation.191Whereas, acute self-
limiting diarrhoea is common in healthy individuals.[11As patients in this study constituted
a combination of healthy and non-HIV immuno-compromised individuals, the clinical
manifestations seen reflected both groups. Nonetheless, clinical manifestations of
microsporidiosis in non-HIV immuno-compromised individuals are almost similar to HIV
patients (pers. comm.).
Other clinical presentations found in this study were loose or watery stool, nausea,
vomiting, cramping abdominal pain and foul smelling stool. These findings are consistent
with the fact that microsporidia generally causes malabsorption even though it is not specific,
and are in agreement with a cohort study done in HIV patients.[19.201Nevertheless, parameters
for malabsorption were not specifically examined such as D-xylose absorption test and
vitamin B 1 2 level [19Jin this study.
This study also showed that patients with intestinal microsporidia had little mucus or
blood in their stools which was in agreement with another study.[IJ In this study, there was
a small percentage of patients presented with mucous and blood in intestinal
microsporidiosis. However, the significance of this association was not examined. It has
been reported that patients with intestinal microsporidia usually have no fever.[19J In this
study, we found that only 1 5 (1 5 .0 % ) patients with intestinal micro sporidia had fever at
presentation. However, we have not demonstrated the significance of association of fever
with microsporidia. Other clinical manifestations such as severe weight loss, wasting, and
malabsorption reported in previous studies, were not observed in this study due to the
limitations mentioned before.
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DLain-lain (Sila nyatakan) / Others
(P lea se specify):
3. Nyatakan masalah utama anda dimasukkan ke dalam wad sekarang (boleh lebih dari satu
masalah):
Main problem for your cur rent admission to the wa rd (can be more than one problem):
4. Sejarah penyakit yang lepas sebelum kemasukan (boleh lebih dari satu)
History of under lying medica l illness pr ior to admission:
D Ya / Yes DTidak / N o DTidak pasti / Not sure
5. Sejarah rawatan penyakit sebelum kemasukan:
History of medica l tr ea tment pr ior to admission:
Sahagian C: Tanda-tanda penyakit Microsporidia Usus
Section C: Signs and Symptoms of Intestina l Microspor idia
Pernahkah anda mengalami tanda-tanda seperti berikut?
Have you ever had the following signs and symptoms?
1. Demam (lebih dari 3 8 S C ) / F ever (more than 38.5°C)
o Ya / Yes 0 Tidak / No 0 Tidak pasti / Not sure
Jika ya, sila jawab soalan yang berikutnya
If yes, plea se answer the following question
a. Jangka masa cirit-birit (tarikh di kira dari hari pertama kemasukan):
Dura tion of dia r rhoea (da te is counted from the fir st day of admission):
b. Kekerapan cirit-birit (berdasarkan bilangan kekerapan membuang najis lembik atau
cairan dalam masa satu hari):
F requency of dia r rhoea (ba sed on the no. of episodes of pa ssing loose or wa tery bowel movements
per day):
3. Najis cair atau lembik / Watery or Loose stool:
o Ya/ Yes o Tidak / No
4. Najis berbau sangat busuk / Foul smelling stools:
o Ya/ Yes 0 Tidak / No
5. Muntah-muntah I vomiting:
D Ya /Yes
6. Rasa mual I nausea:
D Ya /Yes
7. Najis bercampur dengan lendirl Stools mixed with mucus:
D Ya I Yes D Tidak I No D Tidak pasti I Not sure
8. Najis bercampur dengan darah I Stools mixed with blood:
D Ya I Yes D Tidak I No D Tidak pasti I Not sure
9. Sakit kekejangan di bahagian perut I Cramping abdominal pain:
D Ya I Yes D Tidak I No D Tidak pasti I Not sure
10. Pernahkah anda diberi rawatan yang spesifik semasa menpunyai tanda-tanda tersebut?
Have you ever been specifica lly tr ea ted for those signs and symptoms?
D Ya I Yes D Tidak I No D Tidak pasti I Not sure
a. Jika ya, sila nyatakan jenis rawatan (boleh nyatakan lebih dari satu jenis):
If yes, plea se sta te the type(s) of tr ea tment given (can be more than one type):
D Cecair intravena I Intra venous fluid
D Garam rehidrasi oral I Ora l Rehydra tion Sa lts (ORS)
D Antibiotik I Antibiotic
D Lain-lain I Others (Sila nyatakan I P lea se specify): _
Bahagian D: Maklumat organisma di dalam najis
Section D: Informa tion on organism found in the stool
13. Jenis patogen enteric yang dijumpai:
Type of enter ic pa thogen found:
D Microsporidia sahaja I Microspor idia only
D Microsporidia dan lain-lain (sila nyatakan nama spesis) I Microspor idia and other s (plea se
specify name of species):
D Cacing (sila nyatakan nama spesis) I Helminths (plea se specify name of
species): _

